January 2021 Simoa® Publications:
Neurology: Multiple Sclerosis and Traumatic Brain Injury
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
Fernández-Velasco JI, et al.
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940.
Multiple Sclerosis
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
Fissolo N, et al.
Neurology(R) Neuroimmunology & Neuroinflammation. 2021;8.
Multiple Sclerosis
Serum neurofilament levels and patient-reported outcomes in multiple sclerosis
Galetta K, et al.
Annals of Clinical and Translational Neurology. 2021.
Multiple Sclerosis
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
Gelibter S, et al.
Journal of Neurology. 2021.
Multiple Sclerosis
MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis
Rosso M, et al.
J Neuroimaging. 2021.
Multiple Sclerosis
Prolonged elevation of serum neurofilament light after concussion in male Australian football players
McDonald SJ, et al.
Biomark Res. 9, 4 (2021).
Traumatic Brain Injury
January 2021 Simoa® Publications in Other Therapeutic Areas
